Drug Trials Snapshots: FLUORODOPA F 18

10:45 EDT 22 Oct 2019 | FDA

FLUORODOPA F 18 is a drug for the visual detection of certain nerve cells in adult patients with suspected Parkinsonian Syndromes (PS). PS is a group of movement disorders characterized by slow movements, body stiffness, shakiness at rest and inability to maintain posture.

Original Article: Drug Trials Snapshots: FLUORODOPA F 18


More From BioPortfolio on "Drug Trials Snapshots: FLUORODOPA F 18"

Quick Search

Relevant Topic

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...